M&T Bank Corp Talis Biomedical Corp Transaction History

M&T Bank Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	BUY	$0.81 - $1.44 $9,522 - $16,928	11,756 New	11,756 $10,000
Q1 2022 May 09, 2022	SELL	$1.3 - $4.19 $17,771 - $57,277	-13,670 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$3.81 - $6.17 $5,836 - $9,452	-1,532 Reduced 10.08%	13,670 $55,000
Q1 2021 May 06, 2021	BUY	$11.2 - $27.8 $170,262 - $422,615	15,202 New	15,202 $195,000

Ticker TLIS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 26,619,200
Market Cap $45.8M
Description
Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. ...

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

Stay updated on M&T Bank Corp with notifications on news.